PD-L1 was more frequently expressed post-BCG than in BCG-naive tumors (14% vs 7%, p = 0.012), regardless of whether a tumor was considered a BCG failure (14% vs 13%, p > 0.999). The gene discussed is CD274; the disease is neoplasm.